Constellation Pharmaceuticals Garners $15,000,000 Series B Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e96ad44f-d236-4879-88b1-b8256b123c79&Preview=1 - Date
6/6/2011 - Company Name
Constellation Pharmaceuticals - Mailing Address
148 Sidney Street Cambridge, MA 02139 - Company Description
Constellation Pharmaceuticals is the first biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of Epigenetics, a new field of science which is focused on selective regulators of epigenetic function, which are critical to controlling gene expression. - Website
http://www.constellationpharma.com - Transaction Type
Venture Equity - Transaction Amount
$15,000,000 - Transaction Round
Series B - Proceeds Purposes
Proceeds from this round of financing will allow the company to continue to advance product candidates in its portfolio toward clinical development. - M&A Terms
- Venture Investor
Third Rock Ventures - Venture Investor
The Column Group - Venture Investor
Venrock - Venture Investor
SR One
